Latest Licensing News

Xingye Gold has increased its takeover bid for Far East Gold to $0.15 per share, conditional on securing majority ownership by 21 July 2026, and extended the offer period to 29 July. The improved price offers a significant premium amid ongoing project and financial risks at Far East Gold.

Meteoric Resources has surged its Measured Resources by 246% to 128 million tonnes at its Caldeira Rare Earth Element Project in Brazil, significantly de-risking the upcoming Definitive Feasibility Study and underpinning future development plans.

Viridis Mining has boosted the Colossus Project's high-confidence rare earth resource, underpinning debt financing and advancing toward production.

Godolphin Resources is launching an IPO for Matrix Critical Minerals to unlock value in its Narraburra Rare Earths Project, targeting a $8-12 million raise and ASX listing in H2 2026.

Dimerix will provide continued access to its investigational drug DMX-200 for eligible patients with focal segmental glomerular sclerosis after completing the pivotal ACTION3 Phase 3 trial, supporting ongoing treatment ahead of regulatory approval.

Proteomics International has won a key US patent for its PromarkerEndo blood test, bolstering its commercial foothold in the world’s largest healthcare market. The patented technology offers a non-invasive, accurate diagnosis of endometriosis, a condition that currently takes years to detect.

FirstWave Cloud Technology has secured a 12-month extension of its ISM-compliant CyberCision platform agreement with Telstra, increasing annual recurring revenue from Federal Government agencies by 5% to approximately A$0.6 million.

Temas Resources has filed a new patent for its proprietary Regenerative Chloride Leach (RCL) process targeting vanadium extraction, broadening its critical minerals technology portfolio and reinforcing its commercial licensing ambitions.

Imugene has secured $11.12 million through a placement to advance its allogeneic CAR-T therapy azer-cel after early clinical data showed complete responses in BTKi-resistant lymphoma patients.

Argent BioPharma has struck a global licensing deal for its CannEpil® epilepsy therapy with Splash Beverage Group, securing US$5.5 million upfront through convertible debt forgiveness and retaining manufacturing and intellectual property rights alongside a 15% royalty on future sales.

Mount Ridley Mines secures $50,000 co-funding from CSIRO to kick-start research on scandium alloys for additive manufacturing, leveraging one of the world’s largest scandium resources at Grass Patch.

Pure Resources has achieved peer-reviewed validation and in-house production of carbon nanotube fibre fabrics, demonstrating directional heat routing capabilities that could redefine thermal management in data centres and defence electronics.